MedPath

Effect of an exercise-based programTCM Daoyin Prescription for postsurgical non-small cell lung cancer:study protocol for a randomized controlled trial

Phase 1
Recruiting
Conditions
non-small cell lung cancer
Registration Number
ITMCTR2200006061
Lead Sponsor
onghua hospital Shanghai university of traditional chinese medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Inclusion criteria
The eligible participants must meet the following criteria
?aged between 18 and 80 yearshistologically diagnosed with Stage I–IIIA NSCLC according to the 8th edition cancer staging manual of the American Joint Committeeon Cancer and had received surgical therapy;
?Karnofsky performance status of at least =60 at study entry,Neutrophil absolute value > 1.5×109/L, platelet count > 80×109/L, hemoglobin > 100g/L; Normal liver and kidney function and conscious;
?There was no physical disability
?can complete the TCM Daoyin Prescription and the subject has signed an informed consent.

Exclusion Criteria

Exclusion ctiteria include the following:
?The patient's condition is concealed;
?Serious complications of other organs and systems;
?History of mental illness, mental and cognitive disorders;
? Malignant tumor cachexia, systemic metastasis of multiple organs;
?Severe cardiopulmonary insufficiency and uncontrolled persistent tachycardia /bradycardia and other malignant arrhythmias, resting systolic blood pressure > 180mmHg or resting diastolic blood pressure >110mmHg;
? Serious physical diseases, unable to cooperate with sports rehabilitation and other unable to complete the subject designated projects.
? Athletes, patients who participated in other traditional rehabilitation sports, participated in any other clinical studies or took their investigational drugs within the last three months

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath